Atlas Trials

Hepcidin: a Prognostic Marker of Morbidity and Mortality in Severe Sepsis?

Clinical trial NCT03682003 · COMPLETED

Trial details

NCT number
NCT03682003
Sponsor
Rennes University Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Severe Sepsis or Septic Shock
Start date
2014-10-01
Primary completion
2017-07-12
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.